Balyasny Asset Management
DICE

Balyasny Asset Management’s DICE Therapeutics, Inc. Common Stock DICE Stock Holding History

Balyasny Asset Management’s Portfolio DICE Stock Details DICE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-212,700
Closed -$9.88M – 2880
2023
Q2 		$9.88M Buy
+212,700
New +$7.35M 0.02% 788

Balyasny Asset Management's DICE Position: Q3 2023 in Review

Balyasny Asset Management sold out of DICE Therapeutics, Inc. Common Stock (DICE) in Q3 2023, closing a stake of 913,940 shares — an estimated $42.5M sold.

Balyasny Asset Management first reported a position in DICE in Q2 2022 and held it in 4 quarters. The position peaked at $42.5M in Q2 2023. 0 funds tracked by Wall St. Rank hold DICE as of Q3 2023.

  • Balyasny Asset Management reported no remaining DICE Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Balyasny Asset Management sold 913,940 DICE Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $42.5M.
  • Balyasny Asset Management first reported a position in DICE Therapeutics, Inc. Common Stock in Q2 2022 and held it in 4 quarters.
  • Balyasny Asset Management's DICE Therapeutics, Inc. Common Stock position peaked at $42.5M in Q2 2023.
  • 0 funds tracked by Wall St. Rank held DICE Therapeutics, Inc. Common Stock as of Q3 2023.

Based on Balyasny Asset Management's 13F filing for Q3 2023, filed 14 Nov 2023.